§ Federal grant opportunity · RFA-CA-27-003
Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
National Institutes of Health is accepting applications for Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required). The deadline is Rolling / not published and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- Rolling / not published
- Award range
- Award amount not published
- Eligibility
- federally recognized native american tribal governments, county governments, state governments, independent school districts, special district governments, public and indian housing authorities, for profit organizations other than small businesses, public and state institutions of higher education, private institutions of higher education, city or township governments, nonprofits non higher education without 501c3, other native american tribal organizations, nonprofits non higher education with 501c3, other, small businesses
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-CA-27-003
Program overview
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to continue to support the Radiation Oncology-Biology Integration Network (ROBIN) with applications from both new and renewing investigators. This network model will sustain an agile and effective national radiation oncology infrastructure that collectively addresses critical hypothesis-based translational research on the biological basis of responses in cancer patients who undergo radiation treatments. ROBIN supports a collaborative national research network focused on understanding how tumors and normal tissues change biologically during radiation therapy. Because radiation can dynamically alter molecular targets over the course of treatment, the network seeks to generate foundational knowledge that can improve radiation-based cancer care and identify new opportunities for combining radiation with drugs and other therapies. Through multidisciplinary, longitudinal studies, ROBIN centers collect and analyze biospecimens and multimodal data before, during, and after standard-of-care radiation therapy. This work is designed to reveal mechanisms of response, resistance, and toxicity; identify new therapy-induced targets; and determine whether treatment strategies based on initial tumor profiling remain optimal as therapy progresses. The network also strengthens the radiation oncology workforce by integrating expertise in biology, clinical oncology, imaging, dosimetry, omics, biospecimen science, and data science. By sustaining this research infrastructure, NIH aims to accelerate translational discoveries that can inform future clinical trials and improve outcomes for people with cancer.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before Rolling / not published, allowing time for registration and validation.
Related grant opportunities
- ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)
- Forecast to Publish a Funding Opportunity Announcement for Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
- Life and Environments Through Time
- Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)
- Ryan White HIV/AIDS Program Part C Capacity Development Program
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.